The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Promoter Attenuation in Gene Therapy: Interferon- γ and Tumor Necrosis Factor- α Inhibit Transgene Expression
Open accessAbstract
One of the major limitations to current gene therapy is the low-level and transient vector gene expression due to poorly defined mechanisms, possibly including promoter attenuation or extinction. Because the application of gene therapy vectors in vivo induces cytokine production through specific or nonspecific immune responses, we hypothesized that cytokine-mediated signals may alter vector gene expression. Our data indicate that the cytokines interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) inhibit transgene expression from certain widely used viral promoters/enhancers (cytomegalovirus, Rous sarcoma virus, simian virus 40, Moloney murine leukemia virus long terminal repeat) delivered by adenoviral, retroviral or plasmid vectors in vitro. A constitutive cellular promoter (β-actin) is less sensitive to these cytokine effects. Inhibition is at the mRNA level and cytokines do not cause vector DNA degradation, inhibit total cellular protein synthesis, or kill infected/transfected cells. Administration of neutralizing anti-IFN-γ monoclonal antibody results in enhanced transgene expression in vivo. Thus, standard gene therapy vectors in current use may be improved by altering cytokine-responsive regulatory elements. Determination of the mechanisms involved in cytokine-regulated vector gene expression may improve the understanding of the cellular disposition of vectors for gene transfer and gene therapy. Transgene expression can be eliminated even in the presence of substantial amounts of vector DNA in the transduced cells, which suggests that mechanisms other than the antigen-specific immune response may mediate non-cytodestructive events that determine the presence of transgene expression. Our data indicate that the cytokines interferon-γ) (IFN-γ) and tumor necrosis factor-α (TNF-α) inhibit transgene expression from certain widely used viral promoters/enhancers (human cytomegalovirus immediate early, Rous sarcoma virus long terminal repeat, simian virus 40, Moloney murine leukemia virus long terminal repeat) delivered by adenoviral, retroviral, or plasmid vectors in vivo. Inhibition is at the mRNA level and cytokines do not cause vector DNA degradation, inhibit total cellular protein synthesis, or kill infected/transfected cells. Thus, cytokine-regulated promoter function rather than specific immune destruction could limit transgene expression. These results have significant implications for the construction of transfer vectors for human gene therapy because gene transfer vectors could be exposed to a cytokine-rich environment when they are administered in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,298
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
Furth, M. E., Davis, L. J., Fleurdelys, B., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.294-304.1982 · Cited by 800
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
Wong, G. H. W., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 713
Alonso, S., Minty, A., Bourlet, Y., & Buckingham, M. (1986) · Journal of Molecular Evolution · doi:10.1007/bf02100994 · Cited by 643
Samuel, C. E. (1991) · Virology · doi:10.1016/0042-6822(91)90112-o · Cited by 602
Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Widespread long-term gene transfer to mouse skeletal muscles and heart.
Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., & Briand, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115902 · Cited by 580
Xiang, Z., & Ertl, H. C. J. (1995) · Immunity · doi:10.1016/s1074-7613(95)80001-8 · Cited by 477
Adenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.
Hall, C. V., Jacob, P. E., RINGOLD, G. M., & Lee, F. (1983) · PubMed · Cited by 472
Engelhardt, J. F., Ye, X., Doranz, B., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6196 · Cited by 470
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
Horvai, A. E., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., & Glass, C. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1074 · Cited by 422
Challita, P. M., & Kohn, D. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2567 · Cited by 399
Sabath, D. E., Broome, H. E., & Prystowsky, M. B. (1990) · Gene · doi:10.1016/0378-1119(90)90087-8 · Cited by 377
Spitalny, G. L., & Havell, E. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.5.1560 · Cited by 367
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Scharfmann, R., Axelrod, J. H., & Verma, I. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4626 · Cited by 280
Barr, D. M., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson, C. B., Perkins, J. D., & Kay, M. A. (1995) · PubMed · Cited by 235
CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS THE ROLE OF TUMOR NECROSIS FACTOR
Fietze, E., Prösch, S., REINKE, P., Stein, J., Döcke, W., Staffa, G., LÖNING, S., DEVAUX, S., Emmrich, F., BAEHR, R. V., et al. (1994) · Transplantation · doi:10.1097/00007890-199409270-00007 · Cited by 232
Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival
Qin, L., Chavin, K. D., Ding, Y., Tahara, H., Favaro, J. P., Woodward, J. E., Suzuki, T., Robbins, P. D., Lotze, M. T., & Bromberg, J. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2316 · Cited by 185
Self-citationStein, J., Volk, H.-D., Liebenthal, C., Kruger, D. H., & Prosch, S. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2333 · Cited by 173
Harms, J. S., & Splitter, G. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1291 · Cited by 161
Wang, M., Ghosh, S., & Lengyel, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.359 · Cited by 157
Crystal, R. G. (1995) · Nature Medicine · doi:10.1038/nm0195-15 · Cited by 139
Tsui, L. V., Guidotti, L. G., Ishikawa, T., & Chisari, F. V. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12398 · Cited by 132
Human gene therapy — an immature genie, but certainly out of the bottle
Friedmann, T. (1996) · Nature Medicine · doi:10.1038/nm0296-144 · Cited by 118
Philip, R., Brunette, E., Kilinski, L., Murugesh, D. K., McNally, M. A., Uçar, K., Rosenblatt, J. D., OKARMA, T. B., & LEBKOWSKI, J. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2411-2418.1994 · Cited by 114
Rettinger, S. D., Kennedy, S., Wu, X., Saylors, R. L., Hafenrichter, D. G., Flye, M. W., & Ponder, K. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1460 · Cited by 110
Dwarki, V., Belloni, P., Nijjar, T., Smith, J. D., Couto, L. B., Rabier, M. J., Clift, S., Berns, A. J. M., & Cohen, L. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1023 · Cited by 110
Wong, G. H., Tartaglia, L. A., Lee, M. S., & Goeddel, D. V. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3350 · Cited by 97
Karp, S. E., Farber, A., Salo, J. C., Hwu, P., Jaffe, G. S., Asher, A. L., Shiloni, E., Restifo, N. P., Mulé, J. J., & Rosenberg, S. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.896 · Cited by 83
Lægreid, A., Medvedev, A. E., Nonstad, U., Bombara, M. P., Ranges, G. E., Sundan, A., & Espevik, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37355-6 · Cited by 81
Gene Transfer to the Thymus A Means of Abrogating the Immune Response to Recombinant Adenovirus
DeMatteo, R. P., Raper, S. E., Ahn, M., Fisher, K. J., Burke, C., Radu, A. P., Widera, G., Claytor, B. R., Barker, C. F., & Markmann, J. F. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00002 · Cited by 71
Johns, L. D., Sarr, T., & Ranges, G. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5877 · Cited by 48
Gribaudo, G., Ravaglia, S., Gaboli, M. P., Gariglio, M., Cavallo, R., & Landolfo, S. (1995) · Virology · doi:10.1006/viro.1995.1398 · Cited by 48
Wietzerbin, J., Gaudelet, C., CATINOT, L., Chebath, J., & FALCOFF, R. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.48.2.149 · Cited by 19
Cited by
DNA-based therapeutics and DNA delivery systems: A comprehensive review
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070109 · Cited by 630
Brooks, A. R., Harkins, R. N., Wang, P., Qian, H. S., Liu, P., & Rubanyi, G. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.516 · Cited by 362
Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
Rizzuto, G., Cappelletti, M., Maione, D., Savino, R., Lazzaro, D., Costa, P., Mathiesen, I., Cortese, R., Ciliberto, G., Laufer, R., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6417 · Cited by 325
Structure and Function of Lipid-DNA Complexes for Gene Delivery
Chesnoy, S., & Huang, L. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.27 · Cited by 312
Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298
Metadata
- Authors
- Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., & Bromberg, J. S.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1997-11-20
- Volume
- 8
- Issue
- 17
- Pages
- 2019-2029
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1979273971
- Cited by
- 315
- References
- 42
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.